I agree Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.
It finds its uses as an antimalarial compound. It is a lysosomotropic agent, inhibits Plasmodium falciparum, interferes with ferriprotoporphyrin formation and is a weak SERT inhibitor.
Barennes H.; Verdier F.; Clavier F.; Pussard E. Pharmacokinetics of Quinimax suppositories in children with malaria: preliminary study.Clin. Drug Invest.;1999,17287-291.
J M Karle.; I L Karle.; L Gerena and W K Milhous Stereochemical evaluation of the relative activities of the cinchona alkaloids against Plasmodium falciparum.Antimicrob. Agents Chemother.1992,36(7), 1538-1544.
Hazard Statements: H302-H334-H317
Harmful if swallowed. May cause allergy or asthma symptoms or breathing difficulties if inhaled. May cause an allergic skin reaction.
Precautionary Statements: P284-P261-P280g-P342+P311a-P301+P312a-P501a
Wear respiratory protection. Avoid breathing dust/fume/gas/mist/vapours/spray. Wear protective gloves. If experiencing respiratory symptoms: IF SWALLOWED: Dispose of contents/container in accordance with local/regional/national/international regulations.